The Gut Microbiome as a Therapeutic Target in Alopecia Areata: Not Yet Part of the Patient Treatment Plan
Interest in the gut microbiome as a therapeutic target for treating alopecia areata (AA) has grown considerably. However, existing evidence remains limited and inconsistent. Currently, there is insufficient evidence to recommend microbiome-directed testing and therapies to patients with AA. Rigorous longitudinal studies are needed before such interventions can be recommended.
Authors
- Narachai Julanon (ORCID: https://orcid.org/0000-0002-4374-1170)
- Nikhil Pai (ORCID: https://orcid.org/0000-0002-7537-6059)
- Shireen Dumont (ORCID: https://orcid.org/0000-0003-1658-4947)
- Laurence Mainville (ORCID: https://orcid.org/0000-0001-8026-5102)
- Eric P. McMullen (ORCID: https://orcid.org/0000-0001-9961-7999)
- Grace Xiong (ORCID: https://orcid.org/0009-0001-0427-950X)
- Shahnawaz Towheed (ORCID: https://orcid.org/0009-0005-8349-8039)
- Jeffrey C. H. Donovan (ORCID: https://orcid.org/0000-0002-8623-2974)
- Deema Abdel Hafeez
- Romy Shenderey (ORCID: https://orcid.org/0009-0004-8180-7427)
Institutions
- University of British Columbia (CA)
- University of Ottawa (CA)
- Khon Kaen University (TH)
- University of Toronto (CA)
- University Hospital of Geneva (CH)
- Institut de Recherche en Santé Digestive (FR)
- Université Laval (CA)
- McMaster University (CA)
Publication Details
- Journal
- International Journal of Dermatology
- Published
- 2026-04-17
- DOI
- https://doi.org/10.1111/ijd.70437
- Primary Topic
- Hair Growth and Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00